Pacific Sage Partners’s Eli Lilly LLY Stock Holding History

Pacific Sage Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.81M	Sell	1,509 -15	-1%	-$15.3K	0.26%	41
2026 Q1	$1.4M	Buy	1,524 +208	+16%	+$211K	0.22%	45
2025 Q4	$1.41M	Sell	1,316 -56	-4%	-$53.5K	0.22%	42
2025 Q3	$1.05M	Sell	1,372 -2	-0.1%	-$1.49K	0.18%	46
2025 Q2	$1.07M	Sell	1,374 -23	-2%	-$17.9K	0.21%	45
2025 Q1	$1.15M	Hold	1,397	–	–	0.26%	43
2024 Q4	$1.08M	Hold	1,397	–	–	0.25%	41
2024 Q3	$1.24M	Hold	1,397	–	–	0.29%	37
2024 Q2	$1.26M	Buy	1,397 +6	+0.4%	+$4.8K	0.31%	35
2024 Q1	$1.08M	Sell	1,391 -100	-7%	-$71.2K	0.28%	39
2023 Q4	$869K	Sell	1,491 -100	-6%	-$58.4K	0.24%	41
2023 Q3	$855K	Hold	1,591	–	–	0.26%	39
2023 Q2	$746K	Buy	1,591 +22	+1%	+$9.23K	0.22%	38
2023 Q1	$539K	Hold	1,569	–	–	0.17%	42
2022 Q4	$574K	Buy	+1,569	New	+$556K	0.19%	41

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pacific Sage Partners's LLY Position: Q2 2026 in Review

Pacific Sage Partners reduced its Eli Lilly (LLY) stake by 0.98% in Q2 2026, selling an estimated $15.3K and leaving 1,509 shares worth $1.81M. The position accounts for 0.26% of the portfolio, ranked #41.

Pacific Sage Partners first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Pacific Sage Partners held 1,509 shares of Eli Lilly worth $1.81M as of Q2 2026.
Pacific Sage Partners sold 15 Eli Lilly shares in Q2 2026, an estimated $15.3K.
Eli Lilly made up 0.26% of Pacific Sage Partners's portfolio in Q2 2026, its #41 holding.
Pacific Sage Partners first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Pacific Sage Partners's 13F filing for Q2 2026, filed 6 Aug 2026.